Stability of Saxitoxin in 50% Methanol Fecal Extracts and Raw Feces from Bowhead Whales ( Balaena mysticetus )

In recent decades, harmful algal blooms (HABs) producing paralytic shellfish toxins (including saxitoxin, STX) have become increasingly frequent in the marine waters of Alaska, USA, subjecting Pacific Arctic and subarctic communities and wildlife to increased toxin exposure risks. Research on the ri...

Full description

Bibliographic Details
Published in:Marine Drugs
Main Authors: Emily K. Bowers, Raphaela Stimmelmayr, Alicia Hendrix, Kathi A. Lefebvre
Format: Article in Journal/Newspaper
Language:English
Published: MDPI AG 2022
Subjects:
Online Access:https://doi.org/10.3390/md20090547
https://doaj.org/article/0cfdea130ca84e4f93ab8dd726c41cbc
id ftdoajarticles:oai:doaj.org/article:0cfdea130ca84e4f93ab8dd726c41cbc
record_format openpolar
spelling ftdoajarticles:oai:doaj.org/article:0cfdea130ca84e4f93ab8dd726c41cbc 2023-05-15T15:17:07+02:00 Stability of Saxitoxin in 50% Methanol Fecal Extracts and Raw Feces from Bowhead Whales ( Balaena mysticetus ) Emily K. Bowers Raphaela Stimmelmayr Alicia Hendrix Kathi A. Lefebvre 2022-08-01T00:00:00Z https://doi.org/10.3390/md20090547 https://doaj.org/article/0cfdea130ca84e4f93ab8dd726c41cbc EN eng MDPI AG https://www.mdpi.com/1660-3397/20/9/547 https://doaj.org/toc/1660-3397 doi:10.3390/md20090547 1660-3397 https://doaj.org/article/0cfdea130ca84e4f93ab8dd726c41cbc Marine Drugs, Vol 20, Iss 547, p 547 (2022) marine mammals toxin degradation harmful algal bloom toxins storage conditions ELISA saxitoxin Biology (General) QH301-705.5 article 2022 ftdoajarticles https://doi.org/10.3390/md20090547 2022-12-31T00:33:46Z In recent decades, harmful algal blooms (HABs) producing paralytic shellfish toxins (including saxitoxin, STX) have become increasingly frequent in the marine waters of Alaska, USA, subjecting Pacific Arctic and subarctic communities and wildlife to increased toxin exposure risks. Research on the risks of HAB toxin exposures to marine mammal health commonly relies on the sampling of marine mammal gastrointestinal (GI) contents to quantify HAB toxins, yet no studies have been published testing the stability of STX in marine mammal GI matrices. An understanding of STX stability in test matrices under storage and handling conditions is imperative to the integrity of toxin quantifications and conclusions drawn thereby. Here, STX stability is characterized in field-collected bowhead whale feces (stored raw in several treatments) and in fecal extracts (50% methanol, MeOH) over multiple time points. Toxin stability, as the percent of initial concentration (T0), was reported for each storage treatment and time point. STX was stable (mean 99% T0) in 50% MeOH extracts over the 8-week study period, and there was no significant difference in STX concentrations quantified in split fecal samples extracted in 80% ethanol (EtOH) and 50% MeOH. STX was also relatively stable in raw fecal material stored in the freezer (mean 94% T0) and the refrigerator (mean 93% T0) up to 8 weeks. STX degraded over time in the room-temperature dark, room-temperature light, and warm treatments to means of 48 ± 1.9, 38 ± 2.8, and 20 ± 0.7% T0, respectively, after 8 weeks (mean ± standard error; SE). Additional opportunistically analyzed samples frozen for ≤4.5 years also showed STX to be relatively stable (mean 97% T0). Mean percent of T0 was measured slightly above 100% in some extracts following some treatments, and (most notably) at some long-term frozen time points, likely due to evaporation from samples causing STX to concentrate, or variability between ELISA plates. Overall, these results suggest that long-term frozen storage of raw fecal ... Article in Journal/Newspaper Arctic Balaena mysticetus bowhead whale Pacific Arctic Subarctic Alaska Directory of Open Access Journals: DOAJ Articles Arctic Pacific Marine Drugs 20 9 547
institution Open Polar
collection Directory of Open Access Journals: DOAJ Articles
op_collection_id ftdoajarticles
language English
topic marine mammals
toxin degradation
harmful algal bloom toxins
storage conditions
ELISA
saxitoxin
Biology (General)
QH301-705.5
spellingShingle marine mammals
toxin degradation
harmful algal bloom toxins
storage conditions
ELISA
saxitoxin
Biology (General)
QH301-705.5
Emily K. Bowers
Raphaela Stimmelmayr
Alicia Hendrix
Kathi A. Lefebvre
Stability of Saxitoxin in 50% Methanol Fecal Extracts and Raw Feces from Bowhead Whales ( Balaena mysticetus )
topic_facet marine mammals
toxin degradation
harmful algal bloom toxins
storage conditions
ELISA
saxitoxin
Biology (General)
QH301-705.5
description In recent decades, harmful algal blooms (HABs) producing paralytic shellfish toxins (including saxitoxin, STX) have become increasingly frequent in the marine waters of Alaska, USA, subjecting Pacific Arctic and subarctic communities and wildlife to increased toxin exposure risks. Research on the risks of HAB toxin exposures to marine mammal health commonly relies on the sampling of marine mammal gastrointestinal (GI) contents to quantify HAB toxins, yet no studies have been published testing the stability of STX in marine mammal GI matrices. An understanding of STX stability in test matrices under storage and handling conditions is imperative to the integrity of toxin quantifications and conclusions drawn thereby. Here, STX stability is characterized in field-collected bowhead whale feces (stored raw in several treatments) and in fecal extracts (50% methanol, MeOH) over multiple time points. Toxin stability, as the percent of initial concentration (T0), was reported for each storage treatment and time point. STX was stable (mean 99% T0) in 50% MeOH extracts over the 8-week study period, and there was no significant difference in STX concentrations quantified in split fecal samples extracted in 80% ethanol (EtOH) and 50% MeOH. STX was also relatively stable in raw fecal material stored in the freezer (mean 94% T0) and the refrigerator (mean 93% T0) up to 8 weeks. STX degraded over time in the room-temperature dark, room-temperature light, and warm treatments to means of 48 ± 1.9, 38 ± 2.8, and 20 ± 0.7% T0, respectively, after 8 weeks (mean ± standard error; SE). Additional opportunistically analyzed samples frozen for ≤4.5 years also showed STX to be relatively stable (mean 97% T0). Mean percent of T0 was measured slightly above 100% in some extracts following some treatments, and (most notably) at some long-term frozen time points, likely due to evaporation from samples causing STX to concentrate, or variability between ELISA plates. Overall, these results suggest that long-term frozen storage of raw fecal ...
format Article in Journal/Newspaper
author Emily K. Bowers
Raphaela Stimmelmayr
Alicia Hendrix
Kathi A. Lefebvre
author_facet Emily K. Bowers
Raphaela Stimmelmayr
Alicia Hendrix
Kathi A. Lefebvre
author_sort Emily K. Bowers
title Stability of Saxitoxin in 50% Methanol Fecal Extracts and Raw Feces from Bowhead Whales ( Balaena mysticetus )
title_short Stability of Saxitoxin in 50% Methanol Fecal Extracts and Raw Feces from Bowhead Whales ( Balaena mysticetus )
title_full Stability of Saxitoxin in 50% Methanol Fecal Extracts and Raw Feces from Bowhead Whales ( Balaena mysticetus )
title_fullStr Stability of Saxitoxin in 50% Methanol Fecal Extracts and Raw Feces from Bowhead Whales ( Balaena mysticetus )
title_full_unstemmed Stability of Saxitoxin in 50% Methanol Fecal Extracts and Raw Feces from Bowhead Whales ( Balaena mysticetus )
title_sort stability of saxitoxin in 50% methanol fecal extracts and raw feces from bowhead whales ( balaena mysticetus )
publisher MDPI AG
publishDate 2022
url https://doi.org/10.3390/md20090547
https://doaj.org/article/0cfdea130ca84e4f93ab8dd726c41cbc
geographic Arctic
Pacific
geographic_facet Arctic
Pacific
genre Arctic
Balaena mysticetus
bowhead whale
Pacific Arctic
Subarctic
Alaska
genre_facet Arctic
Balaena mysticetus
bowhead whale
Pacific Arctic
Subarctic
Alaska
op_source Marine Drugs, Vol 20, Iss 547, p 547 (2022)
op_relation https://www.mdpi.com/1660-3397/20/9/547
https://doaj.org/toc/1660-3397
doi:10.3390/md20090547
1660-3397
https://doaj.org/article/0cfdea130ca84e4f93ab8dd726c41cbc
op_doi https://doi.org/10.3390/md20090547
container_title Marine Drugs
container_volume 20
container_issue 9
container_start_page 547
_version_ 1766347396150722560